Andrew Oakley
Patrimonio netto: 199 008 $ in data 31/08/2026
Patrimonio netto: 199 008 $ in data 31/08/2026
Andrew J.
Oakley is currently Director at Virometix AG, Executive Director at Novaremed AG, Director at Brian Oakley Ltd. since 2003, Director at Oakley Coachbuilders Ltd. since 2014, Director at UNION Therapeutics A, Director at Metys Pharmaceuticals AG, Independent Director at Tribeca Strategic Acquisition Corp.
starting 2026, and Member of The Institute of Chartered Accountants in Australia since 1987.
Former roles include Non-Executive Chairman at Onconetix, Inc. from 2025 to 2026, CFO, Secretary & Executive Director at Vectura Group Ltd. from 2015 to 2016, Chief Financial Officer, Secretary & Director at Vectura GmbH, Chief Financial Officer & Executive Vice President at Actelion Ltd., Chief Financial Officer & Executive Vice President at Nxera Pharma Co., Ltd. from 2017 to 2018, Chief Financial Officer at NovImmune SA in 2014, Member-Supervisory Board at Ventaleon GmbH, Chief Financial Officer & Executive Vice President at Actelion Pharmaceuticals Ltd. from 2003 to 2013, and Chief Financial Officer & Executive Vice President at Autolus Therapeutics Plc from 2018 to 2023.
Education includes undergraduate studies at Macquarie University and an MBA from London Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,43% | 28/05/2026 | 20.000 ( 0,43% ) | 199 000 $ | 31/08/2026 |
| 13/03/2026 | 13 ( 0% ) | 8 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
The Institute of Chartered Accountants in Australia | Corporate Officer/Principal | 21/05/2010 |
UNION Therapeutics A/S
UNION Therapeutics A/S Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company | Direttore/Membro del Consiglio | - |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Develops safer and more efficacious drugs for chronic and life-threatening diseases | Direttore/Membro del Consiglio | - |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direttore/Membro del Consiglio | - |
Brian Oakley Ltd.
Brian Oakley Ltd. Real Estate DevelopmentFinance Leases and operates real estate properties | Direttore/Membro del Consiglio | 01/04/2003 |
Oakley Coachbuilders Ltd.
Oakley Coachbuilders Ltd. Personnel ServicesCommercial Services Provides human resources provision and management services | Direttore/Membro del Consiglio | 23/06/2014 |
Virometix AG
Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| ONCONETIX, INC. | Presidente | 20/04/2026 |
| AUTOLUS THERAPEUTICS PLC | Direttore Finanziario/CFO | 01/01/2023 |
| ░░░░░ ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 18 |
|---|---|
Vectura Group Ltd.
Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
Macquarie University
Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nxera Pharma Co., Ltd.
Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
Novimmune SA
Novimmune SA BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
The Institute of Chartered Accountants in Australia | |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Develops safer and more efficacious drugs for chronic and life-threatening diseases | Health Technology |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Health Technology |
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and distributes molecular weight drugs | Health Technology |
Virometix AG
Virometix AG BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines and immunotherapeutic drugs for prevention, treatment of infectious & chronic human diseases | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
UNION Therapeutics A/S
UNION Therapeutics A/S Pharmaceuticals: MajorHealth Technology Operates as clinical stage pharmaceutical company | Health Technology |
Metys Pharmaceuticals AG
Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Brian Oakley Ltd.
Brian Oakley Ltd. Real Estate DevelopmentFinance Leases and operates real estate properties | Finance |
Oakley Coachbuilders Ltd.
Oakley Coachbuilders Ltd. Personnel ServicesCommercial Services Provides human resources provision and management services | Commercial Services |
Onconetix, Inc.
Onconetix, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs and diagnostic test for cancers | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale